Pharmather Holdings Stock Investor Sentiment

PHRRF Stock  USD 0.17  0.01  5.56%   
Roughly 62% of Pharmather Holdings' investor base is looking to short. The analysis of current outlook of investing in Pharmather Holdings suggests that many traders are alarmed regarding Pharmather Holdings' prospects. The current market sentiment, together with Pharmather Holdings' historical and current headlines, can help investors time the market. In addition, many technical investors use Pharmather Holdings stock news signals to limit their universe of possible portfolio assets.
Pharmather Holdings otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pharmather daily returns and investor perception about the current price of Pharmather Holdings as well as its diversification or hedging effects on your existing portfolios.
  
over a year ago at news.google.com         
Parkinsons Patients May Benefit From Ketamine, PharmaTher ... - Benzinga
Google News at Macroaxis
over a year ago at news.google.com         
PharmaTher Holdings Submits Fast Track Application to FDA for ... - GuruFocus.com
Google News at Macroaxis
over a year ago at news.google.com         
PharmaTher Holdings Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended Februa...
Google News at Macroaxis
over a year ago at news.google.com         
Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from Ph...
Google News at Macroaxis
over a year ago at news.google.com         
PharmaTher Receives FDA Approval for Phase 2 Clinical Trial on ... - Best Stocks
Google News at Macroaxis
over a year ago at news.google.com         
PharmaTher Holdings Announces Update of Type C Meeting with ... - Financial Post
Google News at Macroaxis
over a year ago at news.google.com         
PharmaTher Holdings Announces Update of Type C Meeting with the FDA for KETARX in Parkinsons Disease...
Google News at Macroaxis
over a year ago at news.google.com         
PharmaDrug partners with PharmaTher to develop DMT transdermal ... - Proactive Investors USA
Google News at Macroaxis
over a year ago at news.google.com         
PharmaTher Submits FDA Meeting Package to Discuss 505 Pathway for New Drug Application of KETARX On-...
Google News at Macroaxis
over a year ago at news.google.com         
Optimi Health submits clinical trial application after developing ... - Mugglehead
Google News at Macroaxis
over a year ago at news.google.com         
Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of ...
Google News at Macroaxis
over a year ago at news.google.com         
PharmaTher One Step Closer to Commercializing Ketamine To ... - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
PharmaTher Holdings Submits FDA Meeting Package to Discuss ... - Marketscreener.com
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharmather Holdings that are available to investors today. That information is available publicly through Pharmather media outlets and privately through word of mouth or via Pharmather internal channels. However, regardless of the origin, that massive amount of Pharmather data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharmather Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharmather Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharmather Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharmather Holdings alpha.

Pharmather Holdings Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharmather OTC Stock analysis

When running Pharmather Holdings' price analysis, check to measure Pharmather Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmather Holdings is operating at the current time. Most of Pharmather Holdings' value examination focuses on studying past and present price action to predict the probability of Pharmather Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmather Holdings' price. Additionally, you may evaluate how the addition of Pharmather Holdings to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments